Security Snapshot

BIO-TECHNE Corp - COMMON STOCK (TECH) Institutional Ownership

CUSIP: 09073M104

13F Institutional Holders and Ownership History from Q3 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

337

Shares (Excl. Options)

70.53MFull value: 70,529,698 · shares · 30 Sep 2026

Price

$72.47

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-7,401,199
Value change
-$527,630,551
Number of holders
337
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
155,444,896
SEC-reported price per share
$72.47
Insider filing price
$72.47
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • TECH - BIO-TECHNE Corp - COMMON STOCK is tracked under CUSIP 09073M104.
  • 337 institutions reported positions in Q3 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 596 to 337 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $12.35BFull value: $12,348,347,967 · USD · 30 Jun 2026
    to
    $5.11BFull value: $5,110,634,195 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 337 institutions filings for Q3 2026.

Open SEC evidence

Security key

09073M104

13F reference period

Q3 2026

13F holders

337

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
TECH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.4% $604,103,180 11,559,571 Vanguard Capital Management 31 Mar 2026
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025
FMR LLC 0.7% -92% $78,855,641 -$845,483,502 1,088,114 -91% FMR LLC 30 Sep 2026
As of 30 Sep 2026, 337 institutional investors reported holding
70.53MFull value: 70,529,698 · shares · 30 Sep 2026
shares of BIO-TECHNE Corp - COMMON STOCK (TECH). This represents 45% of the company’s total
155.44MFull value: 155,444,896 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD CAPITAL MANAGEMENT LLC 6.6% 10,250,628 +0.31% 0.02% $742,863,011
VANGUARD PORTFOLIO MANAGEMENT LLC 4.1% 6,348,862 -2.4% 0.02% $460,102,029
FIL Ltd 4% 6,272,729 +158784% 0.32% $454,584,671
STATE STREET CORP 3.9% 6,045,884 +1.1% 0.01% $438,145,213
GEODE CAPITAL MANAGEMENT, LLC 3.5% 5,431,896 +1.5% 0.02% $393,097,407
Invesco Ltd. 2.4% 3,775,138 -24% 0.02% $273,584,252
MORGAN STANLEY 2.1% 3,329,471 -48% 0.01% $241,286,910
Qube Research & Technologies Ltd 1.5% 2,379,411 0.17% $172,435,915
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.5% 2,321,733 -15% 0.06% $168,229,821
NEUBERGER BERMAN GROUP LLC 1.5% 2,257,292 -21% 0.11% $163,585,964
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.88% 1,374,688 +459% 0.04% $99,623,639
FIRST TRUST ADVISORS LP 0.83% 1,285,722 -6.4% 0.05% $93,176,255
DEUTSCHE BANK AG\ 0.79% 1,228,939 +75% 0.02% $89,061,210
Madison Asset Management, LLC 0.65% 1,017,391 -4.3% 0.92% $73,730,350
Capital Research Global Investors 0.6% 937,246 -64% 0.01% $67,922,218
VANGUARD FIDUCIARY TRUST CO 0.57% 884,192 +0.56% 0.01% $64,077,394
GENEVA CAPITAL MANAGEMENT LLC 0.57% 884,168 -13% 1.8% $64,075,632
Magnetar Financial LLC 0.49% 761,911 0% 0.54% $55,215,690
DIMENSIONAL FUND ADVISORS LP 0.37% 581,538 -74% 0.01% $42,144,012
PICTON MAHONEY ASSET MANAGEMENT 0.37% 580,039 +1060% 0.34% $42,035,442
Border to Coast Pensions Partnership Ltd 0.36% 561,827 -16% 0.56% $40,655,000
WATER ISLAND CAPITAL LLC 0.34% 532,492 +59% 4.1% $38,589,696
Quantinno Capital Management LP 0.32% 491,021 -2.3% 0.03% $35,584,336
Amundi 0.3% 458,623 -75% 0.01% $33,236,409
NUANCE INVESTMENTS, LLC 0.28% 428,379 +305% 5.7% $31,044,608

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Headline period
Q3 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 70,529,698 $5,110,634,195 -$527,630,551 $72.47 337
2026 Q2 175,302,948 $12,348,347,967 -$4,317,066 $70.65 596
2026 Q1 177,412,624 $9,287,936,362 +$263,734,792 $52.26 584
2025 Q4 171,899,789 $10,111,517,379 +$653,769,239 $58.81 583
2025 Q3 158,850,861 $8,835,899,945 +$43,569,058 $55.63 569
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284.00 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .